B
Bergenbio ASA
OTC:BRRGF
Bergenbio ASA
OTC:BRRGF
Price:
97.094
USD
Market Closed
Market Cap:
$38m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Bergenbio ASA
OTC:BRRGF
|
NO |
|
D
|
Darco Water Technologies Ltd
SGX:BLR
|
SG |
|
M
|
MBK PCL
SET:MBK
|
TH |
|
H
|
Hygieia Group Ltd
HKEX:1650
|
SG |
|
Golden Ponder Holdings Ltd
HKEX:1783
|
HK |
|
M
|
Mori-Gumi Co Ltd
TSE:1853
|
JP |
|
Douyu International Holdings Ltd
NASDAQ:DOYU
|
CN |
|
Invert Graphite Ltd
ASX:IVG
|
AU |
|
A
|
Alufluoride Ltd
BSE:524634
|
IN |
|
Territorial'naya Generiruyushchaya Kompaniya No2 PAO
MOEX:TGKB
|
RU |
|
GP Petroleums Ltd
NSE:GULFPETRO
|
IN |
|
P
|
Ping An Insurance Group Co of China Ltd
OTC:PIAIF
|
CN |
Multiples-Based Value
The Multiples-Based Value for Bergenbio ASA (BRRGF) under the Base Case is hidden USD. Compared with the current market price of 97.094 USD, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BRRGF Multiples-Based Value
LOCKED
Multiples Across Competitors
BRRGF Competitors Multiples
Bergenbio ASA Competitors
Bergenbio ASA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NO |
B
|
Bergenbio ASA
OTC:BRRGF
|
19.2m USD | 3.6 | -0.2 | 0.4 | 0.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.8B USD | 6 | 87.2 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.3B USD | 5 | 23.7 | 13.8 | 13.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.9B USD | 5.9 | 20.3 | 12.7 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.3B USD | 9.1 | 27.7 | 20.8 | 21.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.7B USD | 5.6 | 17.8 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3 | 33.1 | 11.1 | 14 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR | 11.3 | 36.2 | 39.4 | 40.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
